Triplex reduces cytomegalovirus complications by half and induces immunity in stem cell transplant

(American College of Physicians) The novel Triplex vaccine reduced rates of cytomegalovirus (CMV) complications in patients undergoing allogeneic hematopoietic stem cell transplant (HCT) by half and induced immunity to the virus. No vaccine-associated safety concerns were identified. Findings from a phase 2 randomized clinical trial are published in Annals of Internal Medicine.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news